Mouse Anti-CRABP2 Recombinant Antibody (CBFYC-0423) (V2LY-1206-LY1065)

Meng, J. F., Luo, M. J., & Li, H. B. (2021). Correlation between Plasma Cellular Retinoic Acid-Binding Protein 2 and Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer Cells. Critical Reviews™ in Eukaryotic Gene Expression, 31(3).

Enikeev, A. D., Komelkov, A. V., Axelrod, M. E., Galetsky, S. A., Kuzmichev, S. A., & Tchevkina, E. M. (2021). CRABP1 and CRABP2 protein levels correlate with each other but do not correlate with sensitivity of breast cancer cells to retinoic acid. Biochemistry (Moscow), 86(2), 217-229.

Kimmel, B. R., & Mrksich, M. (2021). Development of an Enzyme‐Inhibitor Reaction Using Cellular Retinoic Acid Binding Protein II for One‐Pot Megamolecule Assembly. Chemistry–A European Journal, 27(71), 17843-17848.

Sato, H., Narita, S., Ishida, M., Kashima, S., Yamamoto, R., Koizumi, A., ... & Habuchi, T. (2021). Cellular retinoic acid-binding protein 2 enhances saturated fatty acid-induced prostate cancer progression.

Jiao, X., Liu, R., Huang, J., Lu, L., Li, Z., Xu, L., & Li, E. (2020). Cellular Retinoic-Acid Binding Protein 2 in Solid Tumor. Current Protein and Peptide Science, 21(5), 507-516.

Lixa, C., Clarkson, M. W., Iqbal, A., Moon, T. M., Almeida, F. C., Peti, W., & Pinheiro, A. S. (2019). Retinoic acid binding leads to CRABP2 rigidification and dimerization. Biochemistry, 58(41), 4183-4194.

Liu, X., Li, H., Wu, M. L., Wu, J., Sun, Y., Zhang, K. L., & Liu, J. (2019). Resveratrol reverses retinoic acid resistance of anaplastic thyroid cancer cells via demethylating CRABP2 gene. Frontiers in endocrinology, 734.

Mosquera, N., Rodriguez-Trillo, A., Mera-Varela, A., Gonzalez, A., & Conde, C. (2018). Uncovering Cellular retinoic acid-binding protein 2 as a potential target for rheumatoid arthritis synovial hyperplasia. Scientific reports, 8(1), 1-9.

Percicote, A. P., Mardegan, G. L., Gugelmim, E. S., Ioshii, S. O., Kuczynski, A. P., Nagashima, S., & de Noronha, L. (2018). Tissue expression of retinoic acid receptor alpha and CRABP2 in metastatic nephroblastomas. Diagnostic Pathology, 13(1), 1-7.

Fischer-Huchzermeyer, S., Dombrowski, A., Hagel, C., Mautner, V. F., Schittenhelm, J., & Harder, A. (2017). The cellular retinoic acid binding protein 2 promotes survival of malignant peripheral nerve sheath tumor cells. The American journal of pathology, 187(7), 1623-1632.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols